Suppr超能文献

加拿大原住民的肾移植结果。

Kidney transplantation outcomes in Canadian aboriginals.

作者信息

Weber C L C, Rush D N, Jeffery J R, Cheang M, Karpinski M E

机构信息

Department of Medicine, Section of Nephrology, University of British Columbia, Vancouver, Canada.

出版信息

Am J Transplant. 2006 Aug;6(8):1875-81. doi: 10.1111/j.1600-6143.2006.01409.x. Epub 2006 Jun 9.

Abstract

Aboriginal populations experience a very high rate of end-stage renal disease (ESRD); however, little is known about the outcomes of transplantation in this population. We performed a retrospective database review to determine the short- and long-term outcomes of kidney transplantation in Aboriginals. Adult Aboriginal (AB) and Caucasian (C) individuals receiving primary kidney transplants between 1969 and 2003 in Manitoba, Canada were examined. A total of 705 recipients were included (126 AB and 579 C). AB recipients were younger, had different etiologies of ESRD, longer cold-ischemic times for deceased donor transplants, and higher peak panel reactive antibody levels. At 1 year post-transplant, there was no difference in serum creatinine, acute rejection or graft survival between AB and C recipients. However, AB recipients experienced greater weight gains early post-transplant and were more likely to develop post-transplant diabetes mellitus. AB recipients exhibited inferior 10-year graft (AB 26% vs. C 47%, p < 0.01) and patient survival (AB 50% vs. 75%, p < 0.01). When graft survival was censored for death with a functioning graft, there was no difference between the two groups. Multivariate analysis revealed AB race to be an independent predictor of premature graft failure and patient death. In conclusion, kidney transplant outcomes have historically been inferior in the Manitoba population of Canadian Aboriginals.

摘要

原住民人群终末期肾病(ESRD)的发病率非常高;然而,对于该人群的移植结局却知之甚少。我们进行了一项回顾性数据库审查,以确定原住民肾移植的短期和长期结局。对1969年至2003年期间在加拿大曼尼托巴省接受初次肾移植的成年原住民(AB)和白种人(C)个体进行了检查。共纳入705名受者(126名AB和579名C)。AB受者更年轻,ESRD的病因不同, deceased donor移植的冷缺血时间更长,且峰值群体反应性抗体水平更高。移植后1年,AB和C受者之间的血清肌酐、急性排斥反应或移植物存活率没有差异。然而,AB受者在移植后早期体重增加更多,且更有可能发生移植后糖尿病。AB受者的10年移植物存活率(AB为26%,C为47%,p<0.01)和患者存活率(AB为50%,C为75%,p<0.01)较低。当对有功能移植物的死亡进行移植物存活审查时,两组之间没有差异。多变量分析显示AB种族是移植物过早失败和患者死亡的独立预测因素。总之,在加拿大曼尼托巴省的原住民人群中,历史上肾移植结局较差。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验